Page 99 - GTM-3-4
P. 99

Global Translational Medicine





                                        ORIGINAL RESEARCH ARTICLE
                                        Prediction of in-stent restenosis based on

                                        systematic and retrospective analyses



                                        Alina M. Enikeeva 1,2  , Liutsiia Yu. Gazizova 2  , Igor V. Buzaev 1  ,
                                        Irina E. Nikolaeva 1,2  , Irina A. Lakman 3  , Haibo Jia 4  , Tagir Aminov 1,2  ,
                                        Elena A. Badykova 1  , and Naufal Sh. Zagidullin *
                                                                                  1
                                        1 Department of Internal Diseases, Bashkir State Medical University, Ufa, Republic of Bashkortostan,
                                        Russia
                                        2 Department of Cardiology, Republic Cardiological Centre, Ufa, Republic of Bashkortostan, Russia
                                        3 Laboratory for the Study of Socio-Economic Problems of the Regions, Ufa University of Science
                                        and Technology, Ufa, Republic of Bashkortostan, Russia

                                        4 National Key Laboratory of Frigid Zone Cardiovascular Diseases, The Second Affiliated Hospital of
                                        Harbin Medical University, Harbin, Heilongjiang, China
                                        (This article belongs to the Special Issue: Special Issue of Global Translational Medicine in the
                                        Fourth RCCCDT-2024)



                                        Abstract

                                        Coronary restenosis is a pressing challenge in cardiovascular diseases with an
                                        annual incidence of 3 – 4%. The aim of the study was to assess the influence of
                                        known risk factors in predicting coronary restenosis in a systematic analysis and
                                        an original retrospective survey. In the first stage, we performed a systematic
                                        review of restenosis risk factors using the Preferred Reporting Items for Systematic
            *Corresponding author:      Reviews and Meta-Analyses (PRISMA) protocol. In the second stage, we searched
            Naufal Sh. Zagidullin
            (znaufal@mail.ru)           for the restenosis risk factors in 15,000  patients who had undergone coronary
                                        angiography, considering risk factors identified during the first stage. From the
            Citation: Enikeeva AM,
            Gazizova LY, Buzaev IV, et al.   second stage, we identified 516 patients with restenosis versus 282 patients without
            Prediction of in-stent restenosis   restenosis. Coronary risk factors included male sex (hazard ratio [HR] = 2.194;
            based on systematic and     confidence interval [CI]: 1.5 – 3.22) and history of myocardial infarction (HR = 1.098;
            retrospective analyses. Global
            Transl Med. 2024:3(4):4957.   CI: 1.05 – 1.15). Moderate-diameter stenosis (2.75 – 3.5 mm) exhibited a protective
            doi: 10.36922/gtm.4957      effect on restenosis (HR = 0.713; CI: 0.58 – 0.87), whereas small-diameter stenosis did
            Received: September 26, 2024  not. Drug-eluting stents reduced the risk of restenosis (HR = 0.554; CI: 0.41 – 0.75).
                                        The risk factors for coronary restenosis included male sex, history of myocardial
            Accepted: November 22, 2024  infarction, small-diameter stent, and the use of bare-metal stents.
            Published Online: December 26,
            2024
                                        Keywords: Coronary heart disease; Coronary restenosis; Risk factors; Drug-eluting stent;
            Copyright: © 2024 Author(s).   Bare metal stent
            This is an Open-Access article
            distributed under the terms of the
            Creative Commons Attribution
            License, permitting distribution,
            and reproduction in any medium,   1. Introduction
            provided the original work is
            properly cited.             Annually, cardiovascular diseases (CVD) claim millions of lives worldwide and have
                                                                                1
            Publisher’s Note: AccScience   remained the leading cause of mortality for decades.  In Europe, over 60 million potential
            Publishing remains neutral with   years of life are lost annually due to CVD.  According to the Russian Statistical Yearbook
                                                                        2
            regard to jurisdictional claims in   3
            published maps and institutional   2021,  almost half of all deaths result from CVD, with over 80% of them being caused by
            affiliations.               coronary heart disease (CHD). The number of CVD-related deaths per total population
            Volume 3 Issue 4 (2024)                         1                               doi: 10.36922/gtm.4957
   94   95   96   97   98   99   100   101   102   103   104